Management and control of multidrug-resistant tuberculosis (MDR-TB): Addressing policy needs for India
- 1 August 2016
- journal article
- review article
- Published by Springer Nature in Journal of Public Health Policy
- Vol. 37 (3) , 277-299
Abstract
JPHP provides a medium for publication of scholarly articles on the epidemiologic and social foundations of public health policy; presents the results of research bearing on such policy; evaluates administrative experience in the implementation of specific public health policies and programs; and helps make more effective the services provided by health departments, other health agencies, and public health workers in protecting and improving the health of the public.Keywords
This publication has 45 references indexed in Scilit:
- How Did the TB Patients Reach DOTS Services in Delhi? A Study of Patient Treatment Seeking BehaviorPLOS ONE, 2012
- Operational Challenges in Diagnosing Multi-Drug Resistant TB and Initiating Treatment in Andhra Pradesh, IndiaPLOS ONE, 2011
- From Where Are Tuberculosis Patients Accessing Treatment in India? Results from a Cross-Sectional Community Based Survey of 30 DistrictsPLOS ONE, 2011
- Tuberculosis Management by Private Practitioners in Mumbai, India: Has Anything Changed in Two Decades?PLOS ONE, 2010
- Private patient perceptions about a public programme; what do private Indian tuberculosis patients really feel about directly observed treatment?BMC Public Health, 2010
- High levels of multidrug resistant tuberculosis in new and treatment-failure patients from the Revised National Tuberculosis Control Programme in an urban metropolis (Mumbai) in Western IndiaBMC Public Health, 2009
- Upper-Room Ultraviolet Light and Negative Air Ionization to Prevent Tuberculosis TransmissionPLOS Medicine, 2009
- Transmission of MDR and XDR Tuberculosis in Shanghai, ChinaPLOS ONE, 2009
- Pyrazinamide Resistance among South African Multidrug-Resistant Mycobacterium tuberculosis IsolatesJournal of Clinical Microbiology, 2008
- Tuberculosis Chemotherapy: the Influence of Bacillary Stress and Damage Response Pathways on Drug EfficacyClinical Microbiology Reviews, 2006